Target validation and functional analyses using antisense oligonucleotides

Author： Taylor Margaret F  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.5, Iss.3, 2001-06, pp. : 297-301

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

RNAi: for functional analysis and target validation

By Rondinone Cristina M  

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 2, 2006-04 ,pp. : 337-340

Informa Healthcare

Access to resources Recommend Favorite

Topical Delivery of Anti-sense Oligonucleotides Using Low-Frequency Sonophoresis

By Tezel Ahmet   Dokka Sujatha   Kelly Susan   Hardee Gregory E.   Mitragotri Samir  

Pharmaceutical Research, Vol. 21, Iss. 12, 2004-12 ,pp. : 2219-2225

Springer Publishing Company

Access to resources Recommend Favorite

Targeting the Lung Using siRNA and Antisense Based Oligonucleotides

By  

Current Pharmaceutical Design, Vol. 14, Iss. 34, 2008-12 ,pp. : 3620-3627

Bentham Science Publishers

Access to resources Recommend Favorite

Cellular delivery of antisense oligonucleotides

By Lebedeva I.   Benimetskaya L.   Stein C.A.   Vilenchik M.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 50, Iss. 1, 2000-07 ,pp. : 101-119

Elsevier

Access to resources Recommend Favorite

Antisense oligonucleotides as emerging drugs

By Nyce J.W.  

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 365-376

Informa Healthcare

Access to resources Recommend Favorite